Across
- 2. For patients with HAP/VAP due to P. aeruginosa, this antibiotic class is not recommended for monotherapy
- 3. This is the minimum recommended duration of antimicrobial therapy for treatment of CAP
- 6. This is the number of recommended days for antimicrobial treatment of HAP
- 8. Standard empiric therapy for severe CAP includes a beta-lactam and this class of antibiotic
- 9. This agent can be used in patients who test positive for influenza
- 11. This class of antibiotics can be used as monotherapy for initial treatment of CAP
- 13. This lab is used in addition to clinical criteria to guide the discontinuation of antibiotic therapy in HAP/VAP
- 14. Anaerobic coverage for suspected aspiration pneumonia should be added when this is suspected
- 15. Intravenous administration of polymyxins is preferred over this route due to the lack of supporting evidence
Down
- 1. HAP is defined as pneumonia occurring how long after hospital admission
- 4. This glycopeptide antibiotic is used for its MRSA activity
- 5. Due to this side effect of colistin, carbapenems and ampicillin-sulbactam are preferred agents for treating Acinetobacter species
- 7. This tool is used by clinicians to assess the severity of CAP and is preferred over the CURB-65
- 10. It is recommended that empiric antibiotic regimen be guided by this tool which shows local antibiotic-resistance data
- 12. This carbapenem has no activity against P. aeruginosa and should be avoided for treatment of pneumonia due to this organism